Vizille, France Clinical Trials

A listing of Vizille, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 125 clinical trials
Evaluation of Dental Coronal Restorations

The purpose of this study is to provide the latest information on the oral health status of patients, the lifetime of restorations, to quantify the incidence of defects rates on inserted restorations in conservative dentistry. Moreover, the study permits to compare needs of two different patient populations depending on the …

J r me PIEAUD
 (5.2 away) Contact site
  • 3 views
  • 26 Jan, 2021
  • +94 other locations
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

CHU Grenoble Alpes - Hopital /ID# 218437
 (8.0 away) Contact site
  • 93 views
  • 02 Feb, 2021
  • +286 other locations
Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases

To date, the effects of SARS-Cov-2 (Covid-19) on the myocardium and the role it plays in the evolution towards an acute myocarditis are badly understood. The current pandemic of this emerging virus is an opportunity to assess the proportion of acute myocarditis attributable to SARS-Cov-2(Covid-19) and to assess the clinical, …

Cardiology
 (8.0 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +44 other locations
Firazyr Patient Registry (Icatibant Outcome Survey - IOS)

The Icatibant Outcome Survey (IOS) is a prospective, observational disease registry designed to document the routine clinical outcomes over time in participants with angioedema treated with Firazyr (icatibant) and/or Cinryze (C1 inhibitor [human]) in countries where it is currently approved. The data collected will be used to evaluate the safety …

angioedema
c1 inhibitor (human)
icatibant
cinryze
CHU de GRENOBLE
 (8.0 away) Contact site
  • 294 views
  • 25 Jan, 2021
  • +106 other locations
C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (rhC1INH / Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

angioedema
ruconest
c1 inhibitor (human)
Hospital A Michallon, CHU Grenoble
 (9.0 away) Contact site
  • 158 views
  • 25 Jan, 2021
  • +18 other locations
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer

The goal of this project is to characterize the genetic profile of patients with advanced stage IIIB/IV non-small cell lung cancer (NSCLC) using liquid biopsies

erbb2
RET
EGFR
epidermal growth factor
HER2
CHU Grenoble Alpes
 (8.0 away) Contact site
  • 19 views
  • 23 Jan, 2021
  • +11 other locations
Registry for Participants With Short Bowel Syndrome

This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated …

teduglutide
CHU de Grenoble - H pital Albert Michallon
 (8.0 away) Contact site
  • 282 views
  • 16 Jun, 2021
  • +139 other locations
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support biospecimen-based translational research and clinical cancer research, including biomarker discovery to improve the understanding of tumor biology and cancer patients care.

CHU de Grenoble - La Tronche - H pital A. Michallon
 (8.0 away) Contact site
  • 74 views
  • 16 May, 2021
  • +106 other locations
Assessment of the State of Health Quality of Life and Expectations of Patients With Hereditary Angioedema

8 years after the establishment of the therapeutic education program and 14 years after the creation of the National Reference Center for Angioedemas (CREAK), it is necessary to make an inventory in 2021 on the disease experienced by the patient with an assessment the needs and expectations of HAE patients. …

deficiency
angioedema
c1 inhibitor (human)
deficit
CHUGA
 (8.2 away) Contact site
  • 0 views
  • 25 May, 2021
  • 1 location
Prevalence of Chronic Pain After an Emergency Department Visit for Severe Acute Pain

The main objective for investigators is to determine the prevalence of moderate to severe chronic pain in the adult population 6 months after consultation in the emergency department for acute pain (less than 7 days old) and severe pain assessed at admission and defined as greater than or equal to …

Grenoble Alpes University Hospital
 (8.0 away) Contact site
  • 0 views
  • 30 May, 2021
  • +1 other locations